Hospitals are the largest end‑user segment — they see the sickest patients and order the tests. But diagnostic laboratories are the fastest‑growing. The US tularemia market research study shows that labs are growing at over 5% CAGR, driven by reference labs (Quest, LabCorp) offering tularemia PCR and serology.

What's the advantage of a reference lab? They have validated tests and quick turnaround times. The US tularemia market trends highlight that the fastest‑growing end‑user segment is research institutions, which are developing new diagnostics and vaccines.

But hospital labs are still essential for rapid on‑site testing, especially in rural areas.

The bottom line: if you're a doctor, know which tests are available at your local lab vs. reference lab. And if you're a lab manager, consider adding tularemia PCR to your menu — it's a niche, but it saves lives.